Torna all'elenco degli studi

A Study to Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Therapy Versus Lenalidomide Maintenance Therapy Alone in Adult Participants With Newly Diagnosed Multiple Myeloma Who Have Suboptimal Response After Autologous Stem Cell Transplantation (KarMMa-9)

CODICE STUDIO

NCT06045806

TIPOLOGIA

Prima linea giovani, Prima linea anziani

NOME SPONSOR

Bristol-Myers Squibb

DESCRIZIONE

Trattamento

ARM1:
Biological: idecabtagene vicleucel
Specified dose on specified days
Other Names:

  • BMS-986395
  • Abecma
  • bb2121
  • ide-cel

Drug: Lenalidomide
Specified dose on specified days
Other Names:

  • Revlimid
  • LEN

Drug: Fludarabine
Specified dose on specified days
Other Names:

  • FLUDARA
  • BENDARBIN

Drug: Cyclophosphamide
Specified dose on specified days
Other Names:

  • ENDOXAN
  • CYTOXAN

ARM B
Drug: Lenalidomide
Specified dose on specified days
Other Names:

  • Revlimid
  • LEN
Leggi tutto

FARMACI UTILIZZATI

Lenalidomide, Talquetamab (CAR-T)